Llwytho...

Raltegravir in the management of HIV-infected patients

Raltegravir has recently been licensed for the treatment of HIV-1 infection. Currently its use is limited to treatment-experienced patients and subjects with resistant virus. In addition to its activity in the setting of resistance and treatment failure, it appears to have great potential for first-...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awdur: Stellbrink, Hans-Jürgen
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2009
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2761196/
https://ncbi.nlm.nih.gov/pubmed/19920914
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!